Organization Profile

You just read:

Pivotal announces the issuance of two patents both related to the combination of VASCAZEN® with key Cholesterol Lowering Agents (Statins) and Cholesterol Absorption Inhibitors

News provided by

Pivotal Therapeutics Inc.

Feb 10, 2015, 12:28 ET